ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,086.49
0.61%
US Tech 100
20,896.00
1.07%
다우존스 지수
45,014.04
0.69%
Bitcoin
102,631.20
3.92%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Akcea Therapeutics Inc (AKCA) 시세

Akcea Therapeutics Inc

Akcea Therapeutics Inc (AKCA)

NASDAQ
18.17
0.00
(0.00%)
마감 05 12월 6:00AM
15분 지연
0.00
0.00
(0.00%)
시간외 거래: -
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
18.17
매수가
18.08
매도가
19.00
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
18.17
개장가
-
최근 거래 시간
마지막 거래 시간
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

AKCA 최신 뉴스

추가 뉴스

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product PR Newswire BOSTON and CARLSBAD, Calif., Oct. 30, 2020 BOSTON and CARLSBAD, Calif., Oct...

30 10월 2020
PR Newswire (US)

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics Transaction creates a stronger, more efficient company PR Newswire CARLSBAD, Calif., Oct. 12, 2020 CARLSBAD, Calif., Oct. 12...

12 10월 2020
PR Newswire (US)

WAYLIVRA▼® (volanesorsen), the First & Only Therapy for FCS, an Ultra-Rare & Life-Threatening Condition, to Be Available o...

National Institute for Health and Care Excellence (NICE) issues a positive recommendation for volanesorsen to treat adults with Familial Chylomicronaemia Syndrome (FCS) Akcea Therapeutics UK...

18 9월 2020
Business Wire

Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics

Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics - Ionis to acquire remaining 24% of common stock of Akcea it does not already own for $18.15 per share in cash - Transaction...

31 8월 2020
PR Newswire (US)

Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020

Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020 Results from Phase 2 study demonstrate patients receiving vupanorsen experienced significant...

29 8월 2020
PR Newswire (US)

Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020

Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020 Results in late-breaking presentation show patients with hypertriglyceridemia experienced dose-dependent...

29 8월 2020
PR Newswire (US)

Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020

Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020 Late-breaking presentation to focus on efficacy and safety data of vupanorsen in...

24 8월 2020
PR Newswire (US)

Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020

Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020 Data presentation will highlight efficacy, safety and tolerability of...

18 8월 2020
PR Newswire (US)

Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany

Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany WAYLIVRA is the only treatment option for patients with familial chylomicronemia syndrome, or FCS, in...

13 8월 2020
PR Newswire (US)

Akcea Reports Financial Results and Highlights for Second Quarter 2020

Akcea Reports Financial Results and Highlights for Second Quarter 2020 Global Net Product Revenues of $16 Million, an Increase of 66% Year-Over-Year Achieved Pricing and Reimbursement Across Key...

05 8월 2020
PR Newswire (US)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CYCNCyclerion Therapeutics Inc
US$ 6.10
(278.88%)
141.56M
BLUEbluebird bio Inc
US$ 0.7396
(106.30%)
79.23M
SMXSMX Security Matters Public Company
US$ 0.381378
(95.78%)
826.63M
SRMSRM Entertainment Inc
US$ 1.15
(82.51%)
143.64M
CNEYCN Energy Group Inc
US$ 0.5349
(69.49%)
164.13M
RLMDRelmada Therapeutics Inc
US$ 0.6408
(-76.87%)
17.99M
MIGIMawson Infrastructure Group Inc
US$ 0.6885
(-63.95%)
23.35M
MONDMondee Holdings Inc
US$ 0.192
(-34.94%)
4.1M
ORISOriental Rise Holdings Ltd
US$ 8.02
(-32.89%)
675.31k
HTLMHomesToLife Ltd
US$ 3.10
(-27.57%)
162.95k
SMXSMX Security Matters Public Company
US$ 0.381378
(95.78%)
826.63M
SVMHSRIVARU Holding Ltd
US$ 0.023499
(6.81%)
475.49M
HTOOFusion Fuel Green PLC
US$ 0.5199
(63.49%)
279.78M
NVDANVIDIA Corporation
US$ 145.14
(3.48%)
231.22M
CNEYCN Energy Group Inc
US$ 0.5349
(69.49%)
164.13M

AKCA Discussion

게시물 보기
Sidney Sidney 7 년 전
Any thoughts on why so low today?
👍️0
Thoro Thoro 7 년 전
So Volatile. Any thoughts on why the big plunge today?
👍️0
Rodney213 Rodney213 7 년 전
Like how clean the board is .Some heavy price target coverage today
👍️0
dinosaurbob dinosaurbob 7 년 전
Dropped heavy yesterday but bounced back some today. I am still up 17%, so I am not complaining.
👍️0
Thoro Thoro 7 년 전
This is a volatile stock. Its finding its legs.
👍️0
dinosaurbob dinosaurbob 7 년 전
Closed at $15.43 today up 47 cents.
👍️0
dinosaurbob dinosaurbob 7 년 전
Back up $1.02 today. This stock is like riding a roller coaster. Up one day and down the next. And big drops and rises too.
👍️0
dinosaurbob dinosaurbob 7 년 전
WTH happened today? Down $1.52!
👍️0
dinosaurbob dinosaurbob 7 년 전
Closed up 40 cents at $14.88
👍️0
dinosaurbob dinosaurbob 7 년 전
It was up big earlier but steadily dropping now. Still up 14 cents at 2:45 EST
👍️0
Thoro Thoro 7 년 전
AKCA, Akcea and Ionis Announce Submission of Marketing Authorization Application for Volanesorsen to the European Medicines Agency

https://ih.advfn.com/p.php?pid=nmona&article=75321782
👍️0
dinosaurbob dinosaurbob 7 년 전
Closed up at $14.48 (5.16%). Nice!
👍️0
Thoro Thoro 7 년 전
I know it dropped, but I like when it tests higher.
👍️0
dinosaurbob dinosaurbob 7 년 전
Yes, but it dropped to $13.77. I still believe in it though.
👍️0
Thoro Thoro 7 년 전
AKCA $16.30 looked great today!
👍️0
dinosaurbob dinosaurbob 7 년 전
I bought in at 9.88 and then doubled my portfolio Friday at $13.00. I see this over $20.00 by October!
👍️0
Thoro Thoro 7 년 전
AKCA

IPO doing great first 5 days of trading.
👍️0
Thoro Thoro 7 년 전
AKCA

#MARKET NEWS
JULY 14, 2017 / 12:12 PM / 3 DAYS AGO
BRIEF-Akcea Therapeutics Inc shares open at $8.13 in debut vs IPO price of $8/share

http://www.reuters.com/article/brief-akcea-therapeutics-inc-shares-open-idUSFWN1K50CZ




👍️0
Thoro Thoro 7 년 전
AKCA

#MARKET NEWS
JULY 13, 2017 / 8:30 PM / 4 DAYS AGO

BRIEF-Akcea Therapeutics says public offering of 15.6 mln common shares priced at $8 per share

http://www.reuters.com/article/brief-akcea-therapeutics-says-public-off-idUSASA09X2O

👍️0

최근 히스토리

NASDAQ
AKCA
Akcea Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유